博济医药(300404.SZ)发布前三季度业绩，归母净利润2191.39万元，下降49.36%

Core Viewpoint - Boji Pharmaceutical (300404.SZ) reported a revenue of 584 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 5.06% [1] Financial Performance - The net profit attributable to shareholders of the listed company was 21.91 million yuan, representing a year-on-year decrease of 49.36% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 14.98 million yuan, down 57.06% year-on-year [1] - Basic earnings per share stood at 0.0571 yuan [1]